Dimensional analysis of depressive, anxious and somatic symptoms presented by primary care patients and their relationship with ICD-11 PHC proposed diagnoses.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 5 6 2018
medline: 15 5 2020
entrez: 5 6 2018
Statut: ppublish

Résumé

A study conducted as part of the development of the Eleventh International Classification of Mental Disorders for Primary Health Care (ICD-11 PHC) provided an opportunity to test the relationships among depressive, anxious and somatic symptoms in PHC. Primary care physicians participating in the ICD-11 PHC field studies in five countries selected patients who presented with somatic symptoms not explained by known physical pathology by applying a 29-item screening on somatic complaints that were under study for bodily stress disorder. Patients were interviewed using the Clinical Interview Schedule-Revised and assessed using two five-item scales that measure depressive and anxious symptoms. Structural models of anxious-depressive symptoms and somatic complaints were tested using a bi-factor approach. A total of 797 patients completed the study procedures. Two bi-factor models fit the data well: Model 1 had all symptoms loaded on a general factor, along with one of three specific depression, anxiety and somatic factors [x2 (627) = 741.016, p < 0.0011, RMSEA = 0.015, CFI = 0.911, TLI = 0.9]. Model 2 had a general factor and two specific anxious depression and somatic factors [x2 (627) = 663.065, p = 0.1543, RMSEA = 0.008, CFI = 0.954, TLI = 0.948]. These data along with those of previous studies suggest that depressive, anxious and somatic symptoms are largely different presentations of a common latent phenomenon. This study provides support for the ICD-11 PHC conceptualization of mood disturbance, especially anxious depression, as central among patients who present multiple somatic symptoms.

Sections du résumé

BACKGROUND
A study conducted as part of the development of the Eleventh International Classification of Mental Disorders for Primary Health Care (ICD-11 PHC) provided an opportunity to test the relationships among depressive, anxious and somatic symptoms in PHC.
METHOD
Primary care physicians participating in the ICD-11 PHC field studies in five countries selected patients who presented with somatic symptoms not explained by known physical pathology by applying a 29-item screening on somatic complaints that were under study for bodily stress disorder. Patients were interviewed using the Clinical Interview Schedule-Revised and assessed using two five-item scales that measure depressive and anxious symptoms. Structural models of anxious-depressive symptoms and somatic complaints were tested using a bi-factor approach.
RESULTS
A total of 797 patients completed the study procedures. Two bi-factor models fit the data well: Model 1 had all symptoms loaded on a general factor, along with one of three specific depression, anxiety and somatic factors [x2 (627) = 741.016, p < 0.0011, RMSEA = 0.015, CFI = 0.911, TLI = 0.9]. Model 2 had a general factor and two specific anxious depression and somatic factors [x2 (627) = 663.065, p = 0.1543, RMSEA = 0.008, CFI = 0.954, TLI = 0.948].
CONCLUSIONS
These data along with those of previous studies suggest that depressive, anxious and somatic symptoms are largely different presentations of a common latent phenomenon. This study provides support for the ICD-11 PHC conceptualization of mood disturbance, especially anxious depression, as central among patients who present multiple somatic symptoms.

Identifiants

pubmed: 29860958
pii: S0033291718001381
doi: 10.1017/S0033291718001381
pmc: PMC6425363
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

764-771

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

J Psychosom Res. 2009 Sep;67(3):189-97
pubmed: 19686874
CNS Spectr. 2008 May;13(5):379-84
pubmed: 18496475
Gen Hosp Psychiatry. 2012 Nov-Dec;34(6):665-70
pubmed: 22832134
J Pers Assess. 2016;98(3):223-37
pubmed: 26514921
J Affect Disord. 2017 Apr 15;213:199-206
pubmed: 28278448
Psychol Med. 2005 Jul;35(7):1073-82
pubmed: 16045073
Int Rev Psychiatry. 2013 Feb;25(1):65-76
pubmed: 23383668
J Psychosom Res. 2016 Dec;91:48-54
pubmed: 27894462
Gen Hosp Psychiatry. 2008 May-Jun;30(3):191-9
pubmed: 18433651
Psychosom Med. 2007 Dec;69(9):860-3
pubmed: 18040095
Multivariate Behav Res. 2012 Sep 1;47(5):667-696
pubmed: 24049214
Psychol Med. 2012 Jan;42(1):15-28
pubmed: 21682948
J Abnorm Psychol. 2017 Jan;126(1):137-148
pubmed: 27748619
Psychol Methods. 2016 Jun;21(2):137-50
pubmed: 26523435
Clin Psychol Sci. 2014 Mar;2(2):119-137
pubmed: 25360393
J Pers Assess. 2010 Nov;92(6):544-59
pubmed: 20954056
Fam Pract. 2013 Feb;30(1):76-87
pubmed: 22843638
Psychosomatics. 2007 Jul-Aug;48(4):277-85
pubmed: 17600162
Psychol Med. 1992 May;22(2):465-86
pubmed: 1615114
Int Psychiatry. 2011 Feb 01;8(1):1-3
pubmed: 31508060
Fam Pract. 2017 Sep 1;34(5):574-580
pubmed: 28475675
Psychosom Med. 2007 Jan;69(1):30-9
pubmed: 17244846
Ann Fam Med. 2007 Mar-Apr;5(2):126-34
pubmed: 17389536
Psychiatr Clin North Am. 2007 Dec;30(4):593-619
pubmed: 17938036
Braz J Psychiatry. 2011 May;33 Suppl 1:S59-80
pubmed: 21845336

Auteurs

Carolina Ziebold (C)

Universidade Federal de São Paulo, São Paulo,Brazil.

David P Goldberg (DP)

Institute of Psychiatry,King's College London,London,UK.

Geoffrey M Reed (GM)

World Health Organization,Geneva,Switzerland.

Fareed Minhas (F)

Institute of Psychiatry,Rawalpindi,Pakistan.

Bushra Razzaque (B)

Institute of Psychiatry,Rawalpindi,Pakistan.

Sandra Fortes (S)

Rio de Janeiro State University,Rio de Janeiro,Brazil.

Rebeca Robles (R)

National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico,DF,Mexico.

Tai Pong Lam (TP)

University of Hong Kong,Hong Kong,People's Republic of China.

Julio Bobes (J)

University of Oviedo,CIBERSAM,Asturias,Spain.

Celso Iglesias (C)

University of Oviedo,CIBERSAM,Asturias,Spain.

Hugo Cogo-Moreira (H)

Universidade Federal de São Paulo, São Paulo,Brazil.

José Ángel García (JÁ)

National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico,DF,Mexico.

Jair J Mari (JJ)

Universidade Federal de São Paulo, São Paulo,Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH